Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Analysis of a coordinated stroke center and regional stroke network on access to acute therapy and clinical outcomes.

Rymer MM, Armstrong EP, Walker G, Pham S, Kruzikas D.

Stroke. 2013 Jan;44(1):132-7. doi: 10.1161/STROKEAHA.112.666578. Epub 2012 Nov 13.

2.

Analysis of the costs and payments of a coordinated stroke center and regional stroke network.

Rymer MM, Armstrong EP, Meredith NR, Pham SV, Thorpe K, Kruzikas DT.

Stroke. 2013 Aug;44(8):2254-9. doi: 10.1161/STROKEAHA.113.001370. Epub 2013 May 28.

3.

Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.

Xian Y, Federspiel JJ, Grau-Sepulveda M, Hernandez AF, Schwamm LH, Bhatt DL, Smith EE, Reeves MJ, Thomas L, Webb L, Bettger JP, Laskowitz DT, Fonarow GC, Peterson ED.

JAMA Neurol. 2016 Jan;73(1):50-9. doi: 10.1001/jamaneurol.2015.3106.

PMID:
26551916
4.

Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.

Fonarow GC, Zhao X, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Xian Y, Hernandez AF, Peterson ED, Schwamm LH.

JAMA. 2014 Apr 23-30;311(16):1632-40. doi: 10.1001/jama.2014.3203.

PMID:
24756513
5.

Organizing regional networks to increase acute stroke intervention.

Rymer MM, Thrutchley DE; Stroke Team at the Mid America Brain and Stroke Institute..

Neurol Res. 2005;27 Suppl 1:S9-16. Review.

PMID:
16197819
6.

Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.

Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH.

JAMA. 2013 Jun 19;309(23):2480-8. doi: 10.1001/jama.2013.6959.

PMID:
23780461
7.

Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.

Lin CB, Peterson ED, Smith EE, Saver JL, Liang L, Xian Y, Olson DM, Shah BR, Hernandez AF, Schwamm LH, Fonarow GC.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):514-22. doi: 10.1161/CIRCOUTCOMES.112.965210. Epub 2012 Jul 10.

8.

Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.

George MG, Tong X, McGruder H, Yoon P, Rosamond W, Winquist A, Hinchey J, Wall HK, Pandey DK; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2009 Nov 6;58(7):1-23.

9.

Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.

Romano JG, Smith EE, Liang L, Gardener H, Camp S, Shuey L, Cook A, Campo-Bustillo I, Khatri P, Bhatt DL, Fonarow GC, Sacco RL, Schwamm LH.

JAMA Neurol. 2015 Apr;72(4):423-31. doi: 10.1001/jamaneurol.2014.4354.

PMID:
25642650
10.

Geographic differences in acute stroke care in Catalunya: impact of a regional interhospital network.

Ribo M, Molina CA, Pedragosa A, Sanclemente C, Santamarina E, Rubiera M, Delgado-Mederos R, Maisterra O, Quintana M, Alvarez-Sabin J.

Cerebrovasc Dis. 2008;26(3):284-8. doi: 10.1159/000147457. Epub 2008 Jul 23.

PMID:
18648202
11.

Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.

Berlet MH, Stambo GW, Kelley M, Van Epps K, Woeste T, Steffen D.

J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):869-78. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.016. Epub 2013 Sep 5.

PMID:
24011839
12.

Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.

Cucchiara B, Kasner SE, Tanne D, Levine SR, Demchuk A, Messe SR, Sansing L, Lees KR, Lyden P; SAINT Investigators..

Stroke. 2009 Sep;40(9):3067-72. doi: 10.1161/STROKEAHA.109.554386. Epub 2009 Jul 16.

13.
14.

Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.

Uchino K, Massaro L, Jovin TG, Hammer MD, Wechsler LR.

J Stroke Cerebrovasc Dis. 2010 Nov-Dec;19(6):417-23. doi: 10.1016/j.jstrokecerebrovasdis.2009.07.013. Epub 2010 Jun 17.

PMID:
21051004
15.

Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.

Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.

Neurosurgery. 2009 Nov;65(5):860-5; discussion 865. doi: 10.1227/01.NEU.0000358953.19069.E5.

PMID:
19834397
16.

Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.

Grotta JC, Burgin WS, El-Mitwalli A, Long M, Campbell M, Morgenstern LB, Malkoff M, Alexandrov AV.

Arch Neurol. 2001 Dec;58(12):2009-13.

PMID:
11735774
17.

Therapeutic yield and outcomes of a community teaching hospital code stroke protocol.

Asimos AW, Norton HJ, Price MF, Cheek WM.

Acad Emerg Med. 2004 Apr;11(4):361-70.

18.

Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience.

Tanne D, Gorman MJ, Bates VE, Kasner SE, Scott P, Verro P, Binder JR, Dayno JM, Schultz LR, Levine SR.

Stroke. 2000 Feb;31(2):370-5.

19.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

PMID:
21968092
20.

Treating acute stroke patients with intravenous tPA. The OSF stroke network experience.

Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC.

Stroke. 2000 Jan;31(1):77-81.

Supplemental Content

Support Center